Boston Scientific (BSX) earnings per share (EPS)

Earnings per share · fiscal 2025
$1.94

Boston Scientific (BSX) reported diluted earnings per share of $1.94 in fiscal 2025 (the year ended December 31, 2025). That is 55.2% higher than the $1.25 of fiscal 2024. Figures as of 17 Nov 2026, 21:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$1.94
Change on fiscal 2024
+55.2%
Highest on record
$3.33fiscal 2019
Lowest on record
-$2.89fiscal 2012
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Boston Scientific earnings per share (EPS), in more detail

Across the 19 fiscal years on record (2007–2025), the highest was $3.33 in fiscal 2019 and the lowest -$2.89 in fiscal 2012.

History · 19 fiscal years

Earnings per share by fiscal year

Boston Scientific earnings per share (EPS), year by year

Boston Scientific (BSX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$1.94 55.2% up
2024$1.25 16.8% up
2023$1.07 137.8% up
2022$0.45 34.8% down
2021$0.69—
2020-$0.08 102.4% down
2019$3.33 179.8% up
2018$1.19 1,387.5% up
2017$0.08 68.0% down
2016$0.25—
2015-$0.18—
2014-$0.09—
2013-$0.09—
2012-$2.89 1,096.6% down
2011$0.29—
2010-$0.70—
2009-$0.68—
2008-$1.36—
2007-$0.33—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Boston Scientific and comparable companies
CompanyEarnings per shareFiscal year
Takeda Pharmaceutical TAK¥59.822026
Cencora COR$7.962025
Boston Scientific BSX$1.942025
Cardinal Health CAH$7.232026
argenx ARGX$19.572025
Edwards Lifesciences EW$1.832025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BSX

Boston Scientific, figure by figure

Boston Scientific (BSX) overview: price, valuation and scorecardAll health care companies by market value

Boston Scientific earnings per share (EPS): questions and answers

What is Boston Scientific's diluted earnings per share?

Boston Scientific (BSX) reported diluted earnings per share of $1.94 in fiscal 2025 (the year ended December 31, 2025). That is 55.2% higher than the $1.25 of fiscal 2024.

What are the highest and lowest diluted earnings per share figures on record for Boston Scientific?

Across the 19 fiscal years on record (2007–2025), the highest was $3.33 in fiscal 2019 and the lowest -$2.89 in fiscal 2012.

How is Boston Scientific's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Boston Scientific (BSX) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/BSX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.